The increase in Th2 cells with the CXCR3–CCR6– phenotype in blood was closely associated with a poor outcome in patients with severe COVID-19, which made it possible to consider this indicator an independent prognostic marker [118] (Figure 4). The gene discussed is CCR6; the disease is COVID-19.